SF3B1 and neoplasm: Splicing factors mutations are particularly prevalent in myeloid neoplasms; for example, SF3B1, that increases anti-apoptotic isoforms, enhances tumor proliferation and progression, and is associated with poor survival of patients (134, 140, 141, 180, 181).